About Dr. Smiths Biotech Private Limited
Data last updated:
Dr. Smiths Biotech Private Limited is a private limited company based in Pune, Maharashtra, India, a subsidiary of Cian Healthcare Limited. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 April 2015.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24246PN2015PTC154818. Its GSTIN is 05AAFCD3322G1Z5 (Uttarakhand).
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.2 Cr. It is led by directors including Suraj Shriniwas Zanwar and Prakashchandra Rathi.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2023, the company reported a revenue of ₹22.7 Cr, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹95.26 Lakh (net margin 4.2%) and EBITDA of ₹4.08 Cr (EBITDA margin 18%). Revenue has grown at a compounded annual rate (CAGR) of 466% over three years.
The company has about 22 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹16.87 Cr on record. Court records list 10 cases involving the company, including 10 filed against it; 5 cases are pending. The company has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in December 2019. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Inga Laboratories Private Limited with revenue of ₹22.8 Cr. The company has 9 MSME Form 1 returns on record between 2018 and 2022, listing 864 overdue payments to 97 micro and small suppliers.
The last known website on record is drsmiths.co.
Company details
Contact details
Dr. Smiths Biotech Private Limited's registered office is in Pune, Maharashtra. Its website is drsmiths.co. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No. 508 – 511 Sacred World 5th Floor Above Macdonald Vitthal Rao Shivarkar Road W, Anowrie, Pune, Maharashtra, India – 411040
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Dr. Smiths Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dr. Smiths Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Dr. Smiths Biotech Private Limited, buy the company report.
Financials of Dr. Smiths Biotech Private Limited
FY 2023 filings availableDr. Smiths Biotech Private Limited reported revenue of ₹22.7 Cr (up 40% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 466% over three years, including 40% growth in the latest year. EBITDA rose 760% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹22.7 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.08 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹95.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18% | ||||
| Net Profit Margin | 4.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dr. Smiths Biotech Private Limited, buy the company report.
Board of directors of Dr. Smiths Biotech Private Limited
Dr. Smiths Biotech has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suraj Shriniwas Zanwar | Director | 24 Apr 2015 | 11 Years 6 Months | As last reported |
| Prakashchandra Rathi | Director | 11 Sep 2021 | 5 Years 1 Months | As last reported |
| Riyaz Bashir Khan Also directs: Advacare Pharma LLP, Grafychron Media Private Limited | Director | 03 Jun 2019 | 7 Years 4 Months | As last reported |
| Megha Agrawal Also directs: Truenex Absolute Insolvency Resolutions LLP | Irp/Rp/Liquidator | 23 May 2025 | 1 Years 5 Months | As last reported |
Peer comparison
Dr. Smiths Biotech Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Inga Laboratories Private Limited | ₹22.8 Cr (FY 2025) | -4.0% | Mumbai, Maharashtra, India | |||
| Franklin Laboratories India Pvt Ltd | ₹22.76 Cr (FY 2025) | -5.0% | Punjab, India | |||
| Wallace Laboratories Private Limited | ₹22.71 Cr (FY 2023) | 27.0% | Goa, India | |||
| Dr. Smiths Biotech Private Limitedthis company | ₹22.7 Cr (FY 2023) | ₹95.26 Lakh | 4.2% | 40.0% | 22 | Pune, Maharashtra, India |
| Astamed Healthcare ( India ) Private Limited | ₹22.66 Cr (FY 2025) | -10.0% | Mumbai, Maharashtra, India | |||
| Disto Pharmaceuticals Private Limited | ₹22.63 Cr (FY 2024) | -5.0% | Hyderabad, Telangana, India | |||
| Mapaex Remedies Private Limited | ₹22.57 Cr (FY 2017) | -52.0% | Wadhwan, Gujarat, India |
To see the full peer comparison of Dr. Smiths Biotech Private Limited, buy the company report.
Auditor
Dr. Smiths Biotech Private Limited is audited by Hanumantrao Lad & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Hanumantrao Lad & Associates | FY 2023 | 129981W |
Shareholding
The shareholding of Dr. Smiths Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dr. Smiths Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Feb 2022 | 100583479 | Hdfc Bank Limited | ₹7.06 Lakh | Open | |
| 31 Jan 2017 | 100079687 | Sidbi | ₹2 Cr | Open | |
| 31 Jan 2017 | 100079688 | Sidbi | ₹14.8 Cr | Open |
To see the full charge records of Dr. Smiths Biotech Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Dr. Smiths Biotech Private Limited has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in December 2019.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2019 | Secondary share transfer | Undisclosed | Buyer: Cian Healthcare Limited Seller: 2 individuals |
| Oct 2017 | Rights issue | ₹1.6 Cr | Investors: an individual |
| Mar 2017 | Rights issue | ₹3.54 Cr | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Dr. Smiths Biotech Private Limited has 10 court cases on record: 10 filed against it. 5 cases are pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 10 | 5 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Civil suit | Filed against the company by HDFC Bank Ltd Through Amarjit B Pandekar | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed against the company by Globofarm International Private Ltd. | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed against the company by M/S. Alenit Chemicals LLP Through Its Partners | Disposed |
| District court, East, Delhi | Cheque dishonour complaint | Filed against the company by individuals | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Sum.Civ.Suit) | Filed against the company by Vertex Chemicals | Pending |
To see the full case history of Dr. Smiths Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Dr. Smiths Biotech Private Limited has 9 MSME Form 1 returns on record between 2018 and 2022, listing 864 overdue payments to 97 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 97)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Alliance Security Services | |||
| an individual supplier | |||
| Jay Jalaram Enterprise | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Dr. Smiths Biotech Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Dr. Smiths Biotech Private Limited has a workforce of 22 employees on its EPFO records as of Apr 10, 2024, across 2 active EPFO establishments.
GST
Dr. Smiths Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAFCD3322G1Z5 | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dr. Smiths Biotech Private Limited, buy the company report.
Recent activity
Dr. Smiths Biotech Private Limited has 8 board changes on record since 2015: 4 appointments and 4 cessations. The latest: Megha Agrawal was appointed as Irp/Rp/Liquidator on 23 May 2025.
4 earlier events are in the company report.
Frequently asked questions
Dr. Smiths Biotech is undergoing "Corporate Insolvency Resolution Process" (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency resolution professional. The company may not be able to independently enter into new commitments during this period. This is a high-risk status - verify the resolution status before any engagement.
Dr. Smiths Biotech is a company under insolvency, formerly operating as a private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 April 2015 and is registered under CIN U24246PN2015PTC154818. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Dr. Smiths Biotech has 4 current directors:
- Suraj Shriniwas Zanwar - Director
- Prakashchandra Rathi - Director
- Riyaz Bashir Khan - Director
- Megha Agrawal - Irp/Rp/Liquidator
The latest financial statements of Dr. Smiths Biotech on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Dr. Smiths Biotech is U24246PN2015PTC154818. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dr. Smiths Biotech has open charges of ₹16.87 Cr and no satisfied charges on record as per latest MCA filings.
Dr. Smiths Biotech has 10 court cases on record: 10 filed against it. 5 are pending.
Dr. Smiths Biotech was incorporated on 24 April 2015. It is registered with the Registrar of Companies, Pune.
Dr. Smiths Biotech has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in December 2019.
The peers of Dr. Smiths Biotech by revenue are Inga Laboratories Private Limited, Franklin Laboratories India Pvt Ltd, Wallace Laboratories Private Limited, Astamed Healthcare ( India ) Private Limited, Disto Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Megha Agrawal was appointed as Irp/Rp/Liquidator on 23 May 2025. Prakashchandra Rathi ceased to be Additional Director on 24 Nov 2021. Prakashchandra Rathi was appointed as Director on 11 Sep 2021. Dr. Smiths Biotech has 8 board changes on record in total.
Dr. Smiths Biotech has 9 MSME Form 1 returns on record between 2018 and 2022, listing 864 overdue payments to 97 micro and small suppliers. The latest return was filed on 14 Sep 2023.